Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and terpenes for diabetes mellitus and its complications: from mechanisms to new therapies
Esmaeel Ghasemi-Gojani, Igor Kovalchuk, Olga Kovalchuk
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 12, pp. 828-849
Closed Access | Times Cited: 19

Showing 19 citing articles:

Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
Genes (2024) Vol. 15, Iss. 2, pp. 183-183
Open Access | Times Cited: 6
Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases
Bożena Bukowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12738-12738
Open Access | Times Cited: 6
Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6487-6487
Open Access | Times Cited: 13
The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
Psychoactives (2024) Vol. 3, Iss. 1, pp. 48-64
Open Access | Times Cited: 5
Self‐Healing Hydrogel Dressing with Solubilized Flavonoids for Whole Layer Regeneration of Diabetic Wound
Qiang Zeng, Sa Du, Rui Yuan, et al.
Advanced Healthcare Materials (2025)
Open Access
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment
Esmaeel Ghasemi Gojani, Sweta Rai, Farzaneh Norouzkhani, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7621-7667
Open Access | Times Cited: 4
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 8
Anti-Inflammatory Properties of Eugenol in Lipopolysaccharide-Induced Macrophages and Its Role in Preventing β-Cell Dedifferentiation and Loss Induced by High Glucose-High Lipid Conditions
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7619-7619
Open Access | Times Cited: 4
Terpenes in the management of chronic kidney disease
Piyusha Kulkarni, Pranali B. Yeram, Amisha Vora
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6351-6368
Closed Access | Times Cited: 1
Development of efficient and scalable regeneration tissue culture method for Cannabis sativa
Aleksei Sorokin, Igor Kovalchuk
Plant Science (2024) Vol. 350, pp. 112296-112296
Closed Access | Times Cited: 1
Computational insights into the antioxidant and antidiabetic mechanisms of cannabidiol: An in vitro and in silico study
Ochuko L. Erukaınure, Kgalaletso P. Otukile, Karabo R. Harejane, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 7, pp. 104842-104842
Open Access | Times Cited: 3
Effect of THC, CBD, THCV, CBC and CBN Cannabinoids on β-Cells Exposed to High Glucose—High Lipids
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
(2023)
Open Access | Times Cited: 2
In Silico ADME, binding affinities, and properties of synthetic and natural cannabinoid analogs
Maite L. Docampo Palacios, Giovanni A. Ramirez, Tesfay Tesfatsion, et al.
(2023)
Open Access | Times Cited: 2
Use of cannabidiol-dominant extract as co-adjuvant therapy for type 2 diabetes mellitus treatment in feline: case report
José Ignacio Massabo, Gabriela Puiatti, P. Ferrero
Medical Cannabis and Cannabinoids (2024) Vol. 7, Iss. 1, pp. 206-212
Open Access
Les antagonistes des récepteurs aux cannabinoïdes de type 1 (CB1) à action périphérique ont-ils un avenir dans le traitement de l’obésité et du diabète de type 2 ?
Océane Pointeau, Regina María Barbosa, Pascal Degrace, et al.
Médecine des Maladies Métaboliques (2024)
Open Access
The irreversible, towards fatalic neuropathy: from the genesis of diabetes
Bhaskar Pal, Rashmi Ghosh, Raktimava Das Sarkar, et al.
Acta Diabetologica (2024)
Closed Access
Page 1

Scroll to top